Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pharm Pharmacol ; 74(11): 1546-1567, 2022 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-35972442

RESUMO

OBJECTIVES: Ageing is a major cause of multiple age-related diseases. Several mechanisms have been reported to contribute to these abnormalities including glycation, oxidative stress, the polyol pathway and osmotic stress. Glycation, unlike glycosylation, is an irregular biochemical reaction to the formation of active advanced glycation end-products (AGEs), which are considered to be one of the causes of these chronic diseases. This study provides a recent and comprehensive review on the possible causes, mechanisms, types, analytical techniques, diseases and treatments of the toxic glycation end products. KEY FINDINGS: Several mechanisms have been found to play a role in generating hyperglycaemia-induced oxidative stress including an increase in the levels of reactive oxygen species (ROS), increase in the levels of AGEs, binding of AGEs and their receptors (RAGE) and the polyol pathway and thus have been investigated as promising novel targets. SUMMARY: This review focuses on the key mechanisms attributed to cumulative increases of glycation and pathological RAGE expression as a significant cause of multiple age-related diseases, and reporting on different aspects of antiglycation therapy as a novel approach to managing/treating age-related diseases. Additionally, historical, current and possible future antiglycation approaches will be presented focussing on novel drug delivery methods.


Assuntos
Produtos Finais de Glicação Avançada , Hiperglicemia , Humanos , Glicosilação , Produtos Finais de Glicação Avançada/metabolismo , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo , Hiperglicemia/tratamento farmacológico , Receptor para Produtos Finais de Glicação Avançada/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA